Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Ideal and real treatment planning processes for people with serious mental illness in public mental health care.

Treichler EBH, Evans EA, Spaulding WD.

Psychol Serv. 2019 May 23. doi: 10.1037/ser0000361. [Epub ahead of print]

PMID:
31120294
2.

Criminal justice outcomes over 5 years after randomization to buprenorphine-naloxone or methadone treatment for opioid use disorder.

Evans EA, Zhu Y, Yoo C, Huang D, Hser YI.

Addiction. 2019 Aug;114(8):1396-1404. doi: 10.1111/add.14620. Epub 2019 May 2.

PMID:
30916463
3.

Psychosocial and functional contributors to personal recovery in serious mental illness.

Treichler EBH, Li F, O'Hare M, Evans EA, Johnson JR, Spaulding WD.

J Ment Health. 2019 Aug;28(4):427-435. doi: 10.1080/09638237.2018.1521932. Epub 2019 Jan 19.

PMID:
30661426
4.

Multidisciplinary team functioning and decision making within forensic mental health.

Haines A, Perkins E, Evans EA, McCabe R.

Ment Health Rev (Brighton). 2018;23(3):185-196. doi: 10.1108/MHRJ-01-2018-0001. Epub 2018 Sep 10.

5.

Gender Differences in Use of Complementary and Integrative Health by U.S. Military Veterans with Chronic Musculoskeletal Pain.

Evans EA, Herman PM, Washington DL, Lorenz KA, Yuan A, Upchurch DM, Marshall N, Hamilton AB, Taylor SL.

Womens Health Issues. 2018 Sep - Oct;28(5):379-386. doi: 10.1016/j.whi.2018.07.003. Epub 2018 Aug 31.

6.

Collaborative decision skills training: Feasibility and preliminary outcomes of a novel intervention.

Treichler EBH, Avila A, Evans EA, Spaulding WD.

Psychol Serv. 2018 Aug 13. doi: 10.1037/ser0000275. [Epub ahead of print]

PMID:
30102050
7.

Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine/Naloxone in a Multi-Site Trial.

Zhu Y, Evans EA, Mooney LJ, Saxon AJ, Kelleghan A, Yoo C, Hser YI.

J Neuroimmune Pharmacol. 2018 Dec;13(4):488-497. doi: 10.1007/s11481-018-9801-x. Epub 2018 Aug 9.

PMID:
30094695
8.

Validation of an Expanded Carrier Screen that Optimizes Sensitivity via Full-Exon Sequencing and Panel-wide Copy Number Variant Identification.

Hogan GJ, Vysotskaia VS, Beauchamp KA, Seisenberger S, Grauman PV, Haas KR, Hong SH, Jeon D, Kash S, Lai HH, Melroy LM, Theilmann MR, Chu CS, Iori K, Maguire JR, Evans EA, Haque IS, Mar-Heyming R, Kang HP, Muzzey D.

Clin Chem. 2018 Jul;64(7):1063-1073. doi: 10.1373/clinchem.2018.286823. Epub 2018 May 14.

9.

Psychosocial Factors that Shape Substance Abuse and Related Mental Health of Women Military Veterans who Use Community-Based Services.

Evans EA, Glover DL, Washington DL, Hamilton AB.

Subst Use Misuse. 2018 Sep 19;53(11):1878-1892. doi: 10.1080/10826084.2018.1441309. Epub 2018 Feb 27.

PMID:
29485302
10.

Differences by Veteran/civilian status and gender in associations between childhood adversity and alcohol and drug use disorders.

Evans EA, Upchurch DM, Simpson T, Hamilton AB, Hoggatt KJ.

Soc Psychiatry Psychiatr Epidemiol. 2018 Apr;53(4):421-435. doi: 10.1007/s00127-017-1463-0. Epub 2017 Nov 29.

PMID:
29188311
11.

Can the skin make you fat? A role for the skin in regulating adipose tissue function and whole-body glucose and lipid homeostasis.

Caton PW, Evans EA, Philpott MP, Hannen RF.

Curr Opin Pharmacol. 2017 Dec;37:59-64. doi: 10.1016/j.coph.2017.08.011. Epub 2017 Oct 3. Review.

PMID:
28985599
12.

Response to "Noninvasive prenatal screening at low fetal fraction: comparing whole-genome sequencing and single-nucleotide polymorphism methods".

Muzzey D, Haverty C, Evans EA, Goldberg JD.

Prenat Diagn. 2017 Jul;37(7):727-728. doi: 10.1002/pd.5071. No abstract available.

13.

Systematic design and comparison of expanded carrier screening panels.

Beauchamp KA, Muzzey D, Wong KK, Hogan GJ, Karimi K, Candille SI, Mehta N, Mar-Heyming R, Kaseniit KE, Kang HP, Evans EA, Goldberg JD, Lazarin GA, Haque IS.

Genet Med. 2018 Jan;20(1):55-63. doi: 10.1038/gim.2017.69. Epub 2017 Jun 22.

14.

Gender and race/ethnic differences in the persistence of alcohol, drug, and poly-substance use disorders.

Evans EA, Grella CE, Washington DL, Upchurch DM.

Drug Alcohol Depend. 2017 May 1;174:128-136. doi: 10.1016/j.drugalcdep.2017.01.021. Epub 2017 Mar 7.

PMID:
28324815
15.

Noninvasive prenatal screening at low fetal fraction: comparing whole-genome sequencing and single-nucleotide polymorphism methods.

Artieri CG, Haverty C, Evans EA, Goldberg JD, Haque IS, Yaron Y, Muzzey D.

Prenat Diagn. 2017 May;37(5):482-490. doi: 10.1002/pd.5036. Epub 2017 Apr 26.

PMID:
28317136
16.

Gender differences in the effects of childhood adversity on alcohol, drug, and polysubstance-related disorders.

Evans EA, Grella CE, Upchurch DM.

Soc Psychiatry Psychiatr Epidemiol. 2017 Jul;52(7):901-912. doi: 10.1007/s00127-017-1355-3. Epub 2017 Mar 3.

PMID:
28258335
17.

Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessment.

Vysotskaia VS, Hogan GJ, Gould GM, Wang X, Robertson AD, Haas KR, Theilmann MR, Spurka L, Grauman PV, Lai HH, Jeon D, Haliburton G, Leggett M, Chu CS, Iori K, Maguire JR, Ready K, Evans EA, Kang HP, Haque IS.

PeerJ. 2017 Feb 23;5:e3046. doi: 10.7717/peerj.3046. eCollection 2017.

18.

Smith-Lemli-Opitz syndrome carrier frequency and estimates of in utero mortality rates.

Lazarin GA, Haque IS, Evans EA, Goldberg JD.

Prenat Diagn. 2017 Apr;37(4):350-355. doi: 10.1002/pd.5018. Epub 2017 Mar 9.

19.

Care home manager attitudes to balancing risk and autonomy for residents with dementia.

Evans EA, Perkins E, Clarke P, Haines A, Baldwin A, Whittington R.

Aging Ment Health. 2018 Feb;22(2):261-269. doi: 10.1080/13607863.2016.1244803. Epub 2016 Oct 21.

PMID:
27768393
20.

Group Testing Approach for Trinucleotide Repeat Expansion Disorder Screening.

Kaseniit KE, Theilmann MR, Robertson A, Evans EA, Haque IS.

Clin Chem. 2016 Oct;62(10):1401-8. doi: 10.1373/clinchem.2016.259796. Epub 2016 Aug 18.

21.

Modeled Fetal Risk of Genetic Diseases Identified by Expanded Carrier Screening.

Haque IS, Lazarin GA, Kang HP, Evans EA, Goldberg JD, Wapner RJ.

JAMA. 2016 Aug 16;316(7):734-42. doi: 10.1001/jama.2016.11139.

PMID:
27533158
22.

Re: Carrier Screening is a Deficient Strategy for Determining Sperm Donor Eligibility and Reducing Risk of Disease in Recipient Children (From: Silver AJ, Larson JL, Silver MJ, et al. Genet Test Mol Biomarkers 2016;20:276-284).

Wong KK, Goldberg JD, Evans EA, Kang HP, Haque IS.

Genet Test Mol Biomarkers. 2016 Aug;20(8):413-4. doi: 10.1089/gtmb.2016.29019.kkw. No abstract available.

PMID:
27505438
23.

Design and validation of a next generation sequencing assay for hereditary BRCA1 and BRCA2 mutation testing.

Kang HP, Maguire JR, Chu CS, Haque IS, Lai H, Mar-Heyming R, Ready K, Vysotskaia VS, Evans EA.

PeerJ. 2016 Jun 28;4:e2162. doi: 10.7717/peerj.2162. eCollection 2016.

24.

Understanding the Basics of NGS: From Mechanism to Variant Calling.

Muzzey D, Evans EA, Lieber C.

Curr Genet Med Rep. 2015;3(4):158-165. Epub 2015 Sep 4. Review.

25.

Comparison of two- and three-times-daily topical ophthalmic application of 0.005% latanoprost solution in clinically normal dogs.

Tofflemire KL, Whitley EM, Allbaugh RA, Ben-Shlomo G, Robinson CC, Overton TL, Thiessen CE, Evans EA, Griggs AN, Adelman SA, Ludwig AL, Jens JK, Ellinwood NM, Peterson CS, Whitley RD.

Am J Vet Res. 2015 Jul;76(7):625-31. doi: 10.2460/ajvr.76.7.625.

PMID:
26111092
26.

The relevance and implications of organizational involvement for serious mental illness populations.

Treichler EBH, Evans EA, Johnson JR, O'Hare M, Spaulding WD.

Am J Orthopsychiatry. 2015 Jul;85(4):352-361. doi: 10.1037/ort0000051. Epub 2015 Apr 20.

PMID:
25894305
27.

Interviewing and Urine Drug Toxicology Screening in a Pediatric Pain Management Center: An Analysis of Analgesic Nonadherence and Aberrant Behaviors in Adolescents and Young Adults.

Saroyan JM, Evans EA, Segoshi A, Vosburg SK, Miller-Saultz D, Sullivan MA.

Clin J Pain. 2016 Jan;32(1):1-6. doi: 10.1097/AJP.0000000000000231.

28.

Systematic Classification of Disease Severity for Evaluation of Expanded Carrier Screening Panels.

Lazarin GA, Hawthorne F, Collins NS, Platt EA, Evans EA, Haque IS.

PLoS One. 2014 Dec 10;9(12):e114391. doi: 10.1371/journal.pone.0114391. eCollection 2014.

29.

Abuse and misuse of antidepressants.

Evans EA, Sullivan MA.

Subst Abuse Rehabil. 2014 Aug 14;5:107-20. doi: 10.2147/SAR.S37917. eCollection 2014. Review.

30.

Characterization of recycled rubber media for hydrogen sulphide (H2S) control.

Wang N, Park J, Evans EA, Ellis TG.

Environ Technol. 2014 Sep-Oct;35(17-20):2500-5.

PMID:
25145205
31.

Detection of carriers in the Ashkenazi Jewish population: an objective comparison of high-throughput genotyping versus gene-by-gene testing.

Klugman S, Schreiber-Agus N, Nazareth S, Evans EA.

Genet Test Mol Biomarkers. 2013 Oct;17(10):763-7. doi: 10.1089/gtmb.2013.0105. Epub 2013 Aug 17.

PMID:
23952016
32.

Brownian nanoimaging of interface dynamics and ligand-receptor binding at cell surfaces in 3-D.

Kuznetsov IR, Evans EA.

Methods. 2013 Apr 1;60(2):214-24. doi: 10.1016/j.ymeth.2013.03.038. Epub 2013 Apr 30.

PMID:
23643864
33.

Response to Stoll and Resta.

Lazarin GA, Haque IS, Nazareth S, Evans EA.

Genet Med. 2013 Apr;15(4):319-20. doi: 10.1038/gim.2013.19. No abstract available.

34.

Observing force-regulated conformational changes and ligand dissociation from a single integrin on cells.

Chen W, Lou J, Evans EA, Zhu C.

J Cell Biol. 2012 Oct 29;199(3):497-512. doi: 10.1083/jcb.201201091.

35.

An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals.

Lazarin GA, Haque IS, Nazareth S, Iori K, Patterson AS, Jacobson JL, Marshall JR, Seltzer WK, Patrizio P, Evans EA, Srinivasan BS.

Genet Med. 2013 Mar;15(3):178-86. doi: 10.1038/gim.2012.114. Epub 2012 Sep 13.

36.

Toward Fungicidal Management of Laurel Wilt of Avocado.

Ploetz RC, Pérez-Martínez JM, Evans EA, Inch SA.

Plant Dis. 2011 Aug;95(8):977-982. doi: 10.1094/PDIS-08-10-0595.

PMID:
30732110
37.

The expression of nicotinamide N-methyltransferase increases ATP synthesis and protects SH-SY5Y neuroblastoma cells against the toxicity of Complex I inhibitors.

Parsons RB, Aravindan S, Kadampeswaran A, Evans EA, Sandhu KK, Levy ER, Thomas MG, Austen BM, Ramsden DB.

Biochem J. 2011 May 15;436(1):145-55. doi: 10.1042/BJ20101685.

PMID:
21352099
38.

A universal carrier test for the long tail of Mendelian disease.

Srinivasan BS, Evans EA, Flannick J, Patterson AS, Chang CC, Pham T, Young S, Kaushal A, Lee J, Jacobson JL, Patrizio P.

Reprod Biomed Online. 2010 Oct;21(4):537-51. doi: 10.1016/j.rbmo.2010.05.012. Epub 2010 Aug 21.

PMID:
20729146
39.

Pseudomonas aeruginosa suppresses host immunity by activating the DAF-2 insulin-like signaling pathway in Caenorhabditis elegans.

Evans EA, Kawli T, Tan MW.

PLoS Pathog. 2008 Oct;4(10):e1000175. doi: 10.1371/journal.ppat.1000175. Epub 2008 Oct 17.

40.

The DAF-2 insulin-like signaling pathway independently regulates aging and immunity in C. elegans.

Evans EA, Chen WC, Tan MW.

Aging Cell. 2008 Dec;7(6):879-93. doi: 10.1111/j.1474-9726.2008.00435.x. Epub 2008 Sep 8.

41.

Monitoring receptor-ligand interactions between surfaces by thermal fluctuations.

Chen W, Evans EA, McEver RP, Zhu C.

Biophys J. 2008 Jan 15;94(2):694-701. Epub 2007 Sep 21.

42.

Forces and bond dynamics in cell adhesion.

Evans EA, Calderwood DA.

Science. 2007 May 25;316(5828):1148-53. Review.

PMID:
17525329
43.

Ultrasonic monitoring of early-stage biofilm growth on polymeric surfaces.

Kujundzic E, Fonseca AC, Evans EA, Peterson M, Greenberg AR, Hernandez M.

J Microbiol Methods. 2007 Mar;68(3):458-67. Epub 2006 Dec 4.

PMID:
17141898
44.

Heteropolymetallic copper(II)-gold(III) dithiocarbamate [2]catenanes via magic ring synthesis.

Wong WW, Cookson J, Evans EA, McInnes EJ, Wolowska J, Maher JP, Bishop P, Beer PD.

Chem Commun (Camb). 2005 May 7;(17):2214-6. Epub 2005 Mar 14.

PMID:
15856100
45.

High-voltage SPM oxidation of ZrN: materials for multiscale applications.

Farkas N, Comer JR, Zhang G, Evans EA, Ramsier RD, Dagata JA.

Nanotechnology. 2005 Feb;16(2):262-6. doi: 10.1088/0957-4484/16/2/014. Epub 2005 Jan 13.

PMID:
21727433
46.

William Carlos Williams.

Evans EA, Jeste DV.

Am J Geriatr Psychiatry. 2004 Mar-Apr;12(2):129-33; discussion 128.

PMID:
15010341
47.
48.
49.

People make clinical software work, but good direction--and training--is essential.

Evans EA.

Nephrol News Issues. 2001 Jun;15(7):24, 30, 35. Review. No abstract available.

PMID:
12098990
50.

Prospective survey of tick paralysis in dogs.

Atwell RB, Campbell FE, Evans EA.

Aust Vet J. 2001 Jun;79(6):412-8.

PMID:
11491220

Supplemental Content

Loading ...
Support Center